Patents by Inventor Peter Roettgen

Peter Roettgen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANSFER DEVICE FOR TRANSFERRING BULK MATERIAL
    Publication number: 20140212245
    Abstract: A transfer device is configured for transferring bulk material from a barge floating on a body of water into at least one receiving device. At least one lifting lock is provided by way of which the barge can be raised, while floating, to a tilting height above the surface of the body of water, and at least one tilting device is provided by way of which the barge can be tilted such that the bulk material is poured from the barge into the receiving device.
    Type: Application
    Filed: August 10, 2012
    Publication date: July 31, 2014
    Applicant: THYSSENKRUPP RESOURCE TECHNOLOGIES GMBH
    Inventors: Helmut Weber, Peter Roettgen, Wei Ye
  • Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa
    Patent number: 8455627
    Abstract: The present invention is directed to an antibody or derivative thereof of human origin for inhibiting platelet aggregation, characterized in that it is effective by substantially exclusive binding to the activated state of platelet integrin receptor GPIIb/IIIa.
    Type: Grant
    Filed: September 7, 2010
    Date of Patent: June 4, 2013
    Assignee: Affimed Therapeutics, AG
    Inventors: Claudia Linhard, Stefan Knackmuss, Melvyn Little, Karlheinz Peter, Peter Roettgen, Meike Schwarz
  • ANTIBODY OF HUMAN ORIGIN FOR INHIBITING THROMBOCYTES AGGREGATION
    Publication number: 20110165175
    Abstract: The present invention is directed to an antibody or derivative thereof of human origin for inhibiting platelet aggregation, characterized in that it is effective by substantially exclusive binding to the activated state of platelet integrin receptor GPIIb/IIIa.
    Type: Application
    Filed: September 7, 2010
    Publication date: July 7, 2011
    Inventors: Claudia Linhard, Stefan Knackmuss, Melvyn Little, Karlheinz Peter, Peter Roettgen, Meike Schwarz
  • Antibody of human origin specifically binding to activated state of platelet integrin receptor GPIIb/IIIa
    Patent number: 7812136
    Abstract: The present invention is directed to an antibody or derivative thereof of human origin for inhibiting platelet aggregation, characterized in that it is effective by substantially exclusive binding to the activated state of platelet integrin receptor GPIIb/IIIa.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: October 12, 2010
    Assignee: Affimed Therapeutics, AG
    Inventors: Claudia Buettner, Stefan Knackmuss, Melvyn Little, Karlheinz Peter, Peter Roettgen, Meike Schwarz
  • Phagemids and process of preparation
    Patent number: 5925559
    Abstract: The invention concerns a collection of phagemids made up of a promotor, a gene of a fusion between a ligand protein, wherein the ligand protein in its processed state would be of from 40 to 60 amino acid residues, and a bacteriophage protein, at least one transcription terminator sequence, a replication origin derived from a single strand bacteriophage, a plasmid replication origin and facultatively at least one selection marker. Further, the invention concerns a collection of Escherichia coli clones or cells representing the collection of phagemids, a process for isolating phagemid particles with strong binding characteristics for a defined target molecule with the use of collections according to the invention and phagemid particles obtained according to the process.
    Type: Grant
    Filed: June 23, 1997
    Date of Patent: July 20, 1999
    Assignee: Gesellschaft fur Biotechnologische Forschung GmbH
    Inventors: John Collins, Peter Roettgen